Mughal Maleeha, Gabuniya Natiya, Zoccali Giovanni, Roblin Paul, Townley William
From the Department of Plastic Surgery, Guy's and St Thomas Hospital, London, United Kingdom.
Ann Plast Surg. 2020 Sep;85(3):256-259. doi: 10.1097/SAP.0000000000002352.
The medial sural artery perforator (MSAP) flap is an ideal option for reconstruction of oral cavity defects owing to its thin and pliable nature and favorable donor site. Our study presents an assessment of functional outcomes including speech and swallowing in patients with oral cavity tumors reconstructed with MSAP flaps.
Patients undergoing MSAP reconstruction for oral cavity tumors between January 2014 and January 2018 were identified from our prospective head and neck cancer database. Functional outcomes were assessed in conjunction with the Speech and Language Team with a minimum follow-up of 6 months. Function (speech and swallowing) was recorded as a performance status scale set up by the assessing health care professional.
A total of 38 patients underwent reconstruction with the MSAP flap over the study period. The patient cohort included 10 female patients and 28 male patients. The age range was from 30 to 78 years, with a mean age of 56.8 years. Complications included 1 flap loss and 1 donor site wound dehiscence.Most patients (84.2%) had intelligible speech at 6-month follow-up and further improvement at 1 year (92.1%). All patients resumed feeding on postoperative day 4, and only 7.8% (n = 3) of the patients required assistance with feeding at 1-year follow-up.
The MSAP flap provides adequate small-volume replacement for oral cavity reconstructions. Our results indicate that most patients achieve a full diet with no restrictions by 1 year after reconstruction. Most of our patients demonstrated excellent speech with little or no need for repetition in conversation. Over the past few years, this has become the flap of choice for oral cavity reconstruction in our unit.
腓肠内侧动脉穿支(MSAP)皮瓣因其薄且柔韧的特性以及良好的供区条件,是口腔缺损修复的理想选择。我们的研究对采用MSAP皮瓣修复口腔肿瘤患者的功能结局进行了评估,包括言语和吞咽功能。
从我们前瞻性的头颈癌数据库中识别出2014年1月至2018年1月期间接受MSAP修复口腔肿瘤的患者。与言语和语言团队共同评估功能结局,随访时间至少为6个月。功能(言语和吞咽)由评估医疗专业人员按照设定的表现状态量表进行记录。
在研究期间,共有38例患者接受了MSAP皮瓣修复。患者队列包括10例女性患者和28例男性患者。年龄范围为30至78岁,平均年龄为56.8岁。并发症包括1例皮瓣坏死和1例供区伤口裂开。大多数患者(84.2%)在6个月随访时言语清晰,1年时进一步改善(92.1%)。所有患者术后第4天恢复经口进食,1年随访时只有7.8%(n = 3)的患者需要进食辅助。
MSAP皮瓣为口腔修复提供了足够的小体积组织替代。我们的结果表明,大多数患者在修复后1年能够不受限制地正常饮食。我们的大多数患者言语功能良好,交谈中很少或无需重复。在过去几年中,这已成为我们科室口腔修复的首选皮瓣。